We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Eczacıbaşı-Monrol Acquires US Company Capintec

By HospiMedica International staff writers
Posted on 25 Dec 2012
Eczacıbaşı-Monrol (Gebze, Turkey) has acquired Capintec (Ramsey, NJ, USA), a worldwide developer of radiation measurement and protection equipment for nuclear medicine.

Eczacıbaşı-Monrol Nuclear Products has taken a major move towards its goal of global growth by reaching an agreement to acquire Capintec, a developer of radiation measurement and protection products for nuclear medicine.

Capintec has provided sophisticated instrumentation to customers worldwide for 45 years. More...
Its innovative solutions have contributed significantly not only to nuclear medicine but also diagnostic radiology, oncology, endocrinology, and radiation therapy. Capintec’s headquarters are located in Ramsey, and its production plant in Pittsburgh (PA, USA).

Dr. Erdal Karamercan, chairman of the board of Eczacıbaşı-Monrol and president and CEO of the Eczacıbaşı Group, noted that Eczacıbaşı-Monrol took its first step towards strengthening its innovative capacity and growth potential in August 2011, when it acquired Mol-Image. “This acquisition of Capintec, the world’s best-known brand in its field,” he said, “builds on the momentum started with Mol-Image, which develops and manufactures new equipment for nuclear medicine, chemicals, radiopharmaceuticals, and radiation protection products, and represents a major advance in the achievement of our strategic global targets.”

Explaining that the advanced technology products currently manufactured by Mol-Image to US Food and Drug Administration (FDA) standards as well as related technical infrastructure and know-how would be transferred from Mol-Image to Capintec, Dr. Karamercan added, “Drawing on the synergy created by this acquisition, we will market innovative instruments and equipment developed by Capintec and Mol-Image through Eczacıbaşı-Monrol’s extensive sales and distribution channels to reach customers in Turkey, Europe and many other markets around the world.”

To demonstrate the great synergy created by the acquisition, Şükrü Bozluolçay, vice chairman of Eczacıbaşı-Monrol and chairman of the Bozlu Group, noted that Capintec would enable Eczacıbaşı-Monrol to launch its products on the American continent as well expand its product range in Europe, where it is projected there will be three production facilities and sales of EU GMP certified products in five countries by 2013.

Eczacıbaşı-Monrol Nuclear Products manufactures radiopharmaceuticals for diagnosis and treatment at world-class production centers using sophisticated and environmentally sensitive technology. Through continual investments in new technologies and production techniques, Eczacıbaşı-Monrol makes sure that its products and services are of the highest quality, meet the strictest safety standards, and comply with the latest national and international guidelines.

Eczacıbaşı-Monrol has seven production facilities in Turkey, Gebze (headquarters), Ankara, Adana, Izmir, Istanbul, Antalya, and Malatya, and four plants abroad: Romania, Egypt, Kuwait, and Dubai. With the opening of new plants in Jordan, Bulgaria, and Poland in 2013, it will have 14 plants in all.

Capintec is a world-leading supplier of energy measurement products and services focused on developing instrumentation, and services utilizing the most advanced technology. Known for its development, manufacturing, and marketing of state-of-the-art radiation measuring, monitoring and radiation protection instrumentation, Capintec supplies thousands of products as well as new systems for radiation measurement applications worldwide.

Capintec’s sales and administrative headquarters are located in Ramsey (NJ, USA) and its production facility is in Pittsburgh (PA, USA).

Related Links:
Eczacıbaşı-Monrol
Capintec



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.